瘤微环境中的脂质滴:生物发生,功能多样性和治疗向
Jinghan Zhong1,2, Yuqi Liu3, Chenshiyu Wang1,2
1Institute of Pathology and Southwest Cancer Center, Southwest Hospital, Third Military Medical University (Army Medical University), Chongqing 400038, China.
Chinese medical journal
|November 21, 2025
概括
脂质滴 (LDs) 是动态的器官,对癌症的进展和免疫抑制至关重要. 准LD代谢提供了一种新的策略,以破坏瘤存活率并提高免疫治疗的疗效.
科学领域:
- 细胞生物学 细胞生物学
- 癌症生物学 癌症生物学
- 免疫学 免疫学 免疫学
背景情况:
- 脂质滴 (LDs) 曾经被认为是惰性储存场所,但现在被称为动态有机体,调节关键细胞功能.
- 癌细胞利用LD代谢进行增殖,迁移和治疗抵抗.
- 与瘤相关的免疫细胞也使用LD来促进免疫抑制和瘤进展.
研究的目的:
- 审查瘤微环境中的瘤细胞和免疫细胞中脂质滴 (LD) 的作用.
- 探索LD相关蛋白质如何影响免疫抑制和癌症进展.
- 突出针对癌症治疗的LD代谢的治疗策略.
主要方法:
- 文献综述综合了关于LD生物发生,分布和调节的当前知识.
- 专注于LD相关蛋白质及其对瘤微环境的影响.
- 针对LD代谢的治疗策略的分析.
主要成果:
- 乳腺癌积极参与癌细胞的增殖,迁移和抵抗.
- 免疫细胞中的LDs有助于免疫抑制瘤微环境.
- 与LD相关的蛋白质在塑造瘤进展和免疫逃避方面发挥着至关重要的作用.
结论:
- 准LD新陈代谢为癌症治疗提供了一个有前途的治疗途径.
- 同时破坏瘤细胞存活和抵消免疫细胞原始原生效应,可以通过向LDs来实现.
- 将LD向疗法与免疫疗法结合起来,可能为下一代癌症干预提供路线图.
相关概念视频
02:17The Tumor Microenvironment
7.6K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
7.6K
02:57Targeted Cancer Therapies
8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.6K